MARKET CAP: US $ 240BN

CSO & HEAD OF SOCIAL IMPACT: KORAB ZUKA

FOUNDED: 1996 HQ: BASEL, SWITZERLAND

Novartis aims to achieve net zero greenhouse gas emissions across its value chain by 2040, with 2030 targets including a 90 % reduction in Scope 1 and 2 emissions, a 42 % reduction in Scope 3 emissions, and a 30 % reduction in waste sent for disposal. Water stewardship goals include eliminating water-quality impacts and implementing water-reduction plans in stressed regions by 2030. The strategy also focuses on health equity by expanding access to medicines and strengthening healthcare systems in climate-vulnerable regions. Novartis will invest at least US $ 250m in R & D for malaria and neglected diseases from 2026 to 2030 and will launch community health initiatives in 10 low- and middle-income countries. The company emphasises transparent reporting and consistency to ensure lasting impact.“ By embedding inclusion into how we innovate, expanding access to our medicines, strengthening health systems and reducing our environmental footprint,” says Korab Zuka, CSO and Head of Social Impact at Novartis.

Korab Zuka CSO & Head of Social Impact Novartis

44 July 2026